🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Active Not Recruiting
Location
RenJi Hospital
Start Date
2023-07-20
Trial ID
NCT05861102
This is a multi-center, randomized, double-blinded, and placebo-controlled ...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2020-09-08
Trial ID
NCT04312594
Treatments Being Tested
This was a phase 2, single-arm, open-label, non-randomised, multicentre, st...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2021-07-28
Trial ID
NCT04851535
Treatments Being Tested
This multi-center, open-label, parallel-controlled, single-dose Phase 1 stu...
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2021-08-27
Trial ID
NCT04993404
Treatments Being Tested
This is study designed to investigate the efficacy and safety of Jaktinib i...
Status
Completed
Location
The First Affiliated Hospital of China Medical University
Start Date
2021-03-11
Trial ID
NCT04612699
A randomized, double-blind, placebo parallel control study and is expected ...
Status
Unknown
Location
Changsha Taihe Hospital
Start Date
2024-04
Trial ID
NCT05688839
Treatments Being Tested
This study (Unique Protocol ID: ZGJAK020) as an extension of the ongoing "S...
Status
Completed
Location
11 Xizhimen South Street
Start Date
2022-03-25
Trial ID
NCT05255237
Treatments Being Tested
This was an open-label, Multi-center, randomized phase Ⅱ study. Patients wi...
Status
Completed
Location
Chongqing Chinese Traditional Medicine Hospital
Start Date
2019-11-18
Trial ID
NCT04034134
Treatments Being Tested
The primary objective of this study was to assess the effect of rifampicin ...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2021-10-27
Trial ID
NCT06246695
Treatments Being Tested
The purpose of this study is to determine if Jaktinib is safe and effective...
Status
Unknown
Location
Renji Hospital
Start Date
2023-11-10
Trial ID
NCT05861128
Treatments Being Tested